chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received the Pfizer Vaccine at the pharmacy on 12/1/21, my card says "Pfizer Fg8762". During the second, and especially the third day after vaccination I had a swollen left breast. A family friend that is an MD doctor at the Hospital told me that this is Myocarditis. It was painful but not excessively painful and I did not go to the hospital. I was able to continue my job working remotely on the computer. The pain symptom went away after three weeks, and the swelling started to dissipate then and appeared to have completely return to normal after about six weeks.  I also experienced a swollen  lymph node on my left armpit, near where I had received the shot. I tried to keep my left arm up because it would hurt when trying to rest my arm on my side. Other symptoms experienced were fatigue and runny nose.
Redness, swelling that required benadryl to treat. Still bothering the patient over weeks later. This was on the booster dose, but patient had no problems with the first two doses.
Gave KINRIX to infant. Due to KINRIX given -> 2 polios given.
5 min after Vaccine administered pt. fingers started to feel tingly then throat started to feel numb.  BP elevated, alert and responsive.  25 mg Benadryl given  PO 20 min later.  Observed x 1 hour, VS stable, Throat still feeling numb but not worse.   Given 25 mg Benadryl PO and observed 1 more hour.   Pt feels the same,  VS stable, alert and responsive with no resp. distress noted.   Pt. left clinic.     Reached out to pt. several days later with no answer.  Message left with emergency protocol.
pt recv vax 3NOV96 & 24DEC96 pt devel temp, chills, weakness, n/v for 3 to 4 days;MD prescribed antiviral & nausea med;pt has not recovered;
This spontaneous report as received from a registered nurse refers to a 4 year old patient of unknown gender. The reporter stated that on 20-MAY-2014 the patient was vaccinated with a dose of M-M-R II (dose, route and lot# not provided, expiration date 17-MAY-2014). No concomitant medications were reported. No adverse effect reported. Additional information has been requested.
Arthrus reaction at site 4 x 4cm (LA) and Uticaria on cheeks.
pt was given fluzone HD quad for pt's over 65yrs old. She is only 61 yrs old.
Patient felt faint and had blurred vision.  Resolved on its own.  Patient was given a bottle of water.  Patient went home ambulatory.
Baby stopped growing 5 days after shot, confirmed with ultrasounds on 4/26 and 5/6; Maternal exposure during pregnancy, first trimester; This is a spontaneous report from a contactable consumer (fetus's mother). This consumer reported information for both mother and fetus. This is the fetus report. A patient (fetus) mother (35-years-old ) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 18Apr2021 09:15 (Batch/Lot Number: EW0164) at the age of 35-years-old as single dose, dose 1 via an unspecified route of administration, administered in Arm Left on 28Mar2021 15:00 (Batch/Lot Number: Er8732) at the age of 35-years-old as single dose for covid-19 immunisation. Route of the administration for fetus was provided as Transplacental. The patient's mother medical history was not reported. The patient's mother's concomitant medication included estradiol (ESTRACE) taken for an unspecified indication, start and stop date were not reported; progesterone taken for an unspecified indication, start and stop date were not reported. The patient's mother did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The baby experienced maternal exposure during pregnancy, first trimester from 28Mar2021 15:00. On 23Apr2021, 14:00, the mother experienced miscarriage, the baby stopped growing 5 days after shot 23Apr2021 14:00, confirmed with ultrasounds 26Apr2021 and 06May2021, the event resulted in doctor or other healthcare professional office/clinic visit, there was no treatment for event. Mother's Last menstrual date was 10Mar2021. The outcome of the events was fatal.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021509131 mother case; Reported Cause(s) of Death: Baby stopped growing 5 days after shot, confirmed with ultrasounds on 4/26 and 5/6; Maternal exposure during pregnancy, first trimester
MUSCLE ACHES SIX WEEKS AFTER GETTING VACCINE; This spontaneous report received from a parent concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced muscle aches six weeks after getting vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of muscle aches six weeks after getting vaccine was not reported. This report was non-serious.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Nurse). The reporter is the patient.  A 29-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Jan2021 as dose 1, single (Lot number: EL3302), in left arm, on 04Feb2021 as dose 2, single (Lot number: EL9264), in left arm and on 25Oct2021 as dose 3 (booster), single (Lot number: EW0183) at the age of 29 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "ulcerative colitis" (unspecified if ongoing). Concomitant medication(s) included: XYZAL; ALBUTEROL [SALBUTAMOL]; SYMBICORT. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown Results; (22Jun2022) Negative; (28Jun2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events with the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available.
Case had received both doses of Moderna Covid 19 vaccine 1= 3/4/2021 LOT# 014M20A 2 = 4/2/2021 LOT# 016B21A Covid 19 symptom onset 08/06/2021 Tested on 8/10/21 with positive result
Narrative: Patient is a 80 year old MALE who received the 1st dose of COVID vaccine 3/3/21. Spoke w/pt today RE: adverse reaction related to the vaccination. ------------------------------------------------------- ----------------SYMPTOMS: Fever No if yes temp: n/a Fatigue No Myalgia No Arthralgia No Rash/Hives No SOB No Bell's Palsy No Injection Site Reaction Yes Other No If yes describe: arm discomfort x1 day
Post vax, the pt developed edema on right arm and hives. 11 cm in diameter.
12/18/2020, 11pm, swollen itchy hands duration 7 hours, 12/19/2020, 6am swollen itchy hands and feet duration 5 hours, 12/19/20, 12pm body rash/arms, legs, abdomen duration 2 hours, 12/19/20, 3pm  B/L UE lymphadenopathy duration 3 hours,  12/19/20, 8pm, injection site/L arm/shoulder/L clavicle swollen duration 3 hours.
Hospitalized approximately 10 days following anthrax vaccine.  Developed upper respiratory illness-bronchitis, leading to hospitalization for asthmatic exacerbation. Follow-up: The following was an update on patient's status obtained by phone today: Patient had a military medical board evaluation and received a disability rating of 50%. She was permanently medically retired. She continued to suffer with symptoms of chronic fatigue, COPD, fibromyalgia, and cognitive deficits. Patient reported that her rheumatoid factor is positive and she was started on PLAQUENIL 2 weeks ago. I have requested that patient send copies of her most recent medical records and I will forward any records that I receive.
receiving 2nd dose from a expired vaccine; wrong interval of days between doses; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (receiving 2nd dose from a expired vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (wrong interval of days between doses) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038c21a and 037c21a) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (receiving 2nd dose from a expired vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (wrong interval of days between doses). On 04-Aug-2021, EXPIRED PRODUCT ADMINISTERED (receiving 2nd dose from a expired vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (wrong interval of days between doses) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information were provided. No treatment information were provided.
Adverse Event - 3-3-21 On right upper arm where the vaccine injection site,   Large circular area (7" x 6"), outlined with redness and bruising.  Within the circular area a red circular patchy area appears, not as well defined as the outer circular area. Symptoms- none involved with the reaction site. Signs-none other than bruising and redness. Time course - exactly 21 days post vaccine injection. Treatments- none - no symptoms to treat at this time. Outcome -   Large circular area (7" x 6"), outlined with redness and bruising.  Within the circular area a red circular patchy area appears, not as well defined as the outer circular area.   Area is not being treated at this time as there are no symptoms.
Migraine and fatigue on the day of vaccination. Reported on 23 April 2015, rash and redness to the right neck, swollen lymph nodes to the right neck. Prev Med nurse reported 80mm redness and nodule to the left upper arm near injection site. Small bumps to bilateral upper portion of face. Complain of difficulty of breathing for one night. Complain of itchy to the left arm.
After recieving the flu shot, around the site it felt like my upper arm was heavy/asleep, and as the day went by the rest of my arm felt the same way.  I thought it would be gone by the next day.  Later that night, around 11 pm I woke up with my entire right hand feeling numb, tingling and a little painful.  It didn't matter how I laid in bed or the position of my arm/hand.  It would only somewhat go away if I was sitting up/standing.  This happens through out the night, every night since the shot.  I also get some of the numbness/tingling during the day (most part of the day my arm/hand feels heavy and asleep), but is worse at night and keeps me up all night.  I went to the employee health doctor with my concern on 12/05/2014 since this has not went away
This spontaneous report as received from a 65 year old female patient refers to herself. Patient had drug reaction/allergies to morphine. On unknown date (reported as "about two and a half years ago") patient received dose of ZOSTAVAX (1 injection, dose and route of administration not provided). Concomitant therapy included amlodipine. On 30-SEP-2014 the patient experienced shingles outbreak starting with shoulder blade pain and followed with excruciating pain tingling and extreme tiredness. On 06-OCT-2014 patient felt tingling and saw a blistering rash, which started in the middle of her back and continued to spread to the front side going into her breast area. No lab diagnostic studies were performed. Patient sought medical attention. On 04-OCT-2014 the patient experienced symptoms that mimicked a heart attack, due to those symptoms, patient was hospitalized for 2 days (04-OCT-2014 and 05-OCT-2014). The outcome of the events was reported as not recovered/not resolved. Relatedness between events and vaccination with ZOSTAVAX was not reported. Upon internal review symptoms that mimicked a heart attack were considered to be medically significant. Additional information is not expected. Physician did not wish to be contacted.
This case was reported by a consumer and described the occurrence of feeling bad in a female patient who received BEXSERO. Previously administered products included BEXSERO (received in December 2016). On 1st February 2018, the patient received BEXSERO. On 1st February 2018, less than a day after receiving BEXSERO, the patient experienced feeling bad and drug dose administered interval too long. On an unknown date, the outcome of the feeling bad and drug dose administration interval too long were unknown. It was unknown if the reporter considered the feeling bad to be related to BEXSERO. Additional details were reported as follows: The age at vaccination was not reported. The patient was the reporter's daughter. In February 2018, almost 2 years after 1st dose, the patient was inadvertently given a dose of BEXSERO, which led to lengthening of the vaccination schedule. Her college contacted her and told her she needed an additional dose that she received yesterday. The patient was feeling very poorly on the day of reporting. The reporter wanted to know if this was a concern.
This case involves an adult patient who had flu (influenza) after receiving INFLUENZA VACCINE. The patient had no medical history, concomitant disease or risk factor. The patient medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer [lot number and expiry date not reported] via unknown route in unknown administration site for prophylactic vaccination. On an unknown date the patient developed a non-serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE. It was reported "Last time I got a flu shot I got the flu." There were no lab data/results available. It was unknown if the patient experienced any additional symptoms/events. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was unknown for the reported event. There will be no information on the batch number for this case.
She violently was throwing up, had severe diarrhea and severe vomiting's for 3 days.; She violently was throwing up, had severe diarrhea and severe vomiting's for 3 days.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 22 year-old female patient received bnt162b2 (BNT162B2) (Lot number: ER8729) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIARRHOEA (non-serious), VOMITING (non-serious), outcome "unknown" and all described as "She violently was throwing up, had severe diarrhea and severe vomiting's for 3 days".  Additional information: Patient received the vaccine, the Pfizer vaccine. Patient was 22 years old, had it about Friday morning and on Sunday afternoon patient violently was throwing up, had severe diarrhea and severe vomiting's for 3 days.   No follow-up attempts are possible. No further information is expected.
Tender feeling in armpit (potential swollen lymph node) 1 week after vaccine. Vaccine received  late afternoon Friday April 9. Only symptom immediately with in the 1-2 days after receiving vaccine was extra tiredness. Armpit tenderness was only noticed in the early AM of Saturday April 17 (1-2AM) before sleeping.
This spontaneous report was received from a nurse referring to a 25 years old patient of unknown gender. Information about concomitant medication, medical history and drug reactions/allergies was not provided. On 12-SEP-2018, the patient was vaccinated with PROQUAD (lot # N021725, expiration date 06-FEB-2019, therapy type: rHA (recombinant Human albumin); strength, dose detail and route were not reported) for prophylaxis, inadvertently instead of MMR II. No adverse effects were reported.
After patient was given the above mentioned vaccines mother was redressing patient when she noted what she called a "rash" on both the patient's back and stomach. No rash was noted on the stomach. On the back there were a few slightly raised areas the same color as the skin with scattered dried areas noted. No shortness of breath. No problems breathing. Patient kept under close observation for 30 minutes. No increase in areas of concern. No problems breathing. No shortness of breath. Mother is planning to take patient to his pediatrician for further evaluation when leaving clinic. Phone call to patient's mother to check on patient. Mother took patient to his pediatrician after vaccines today. Mother states patient is "fine". Pediatrician gave her a prescription for a combination of BENADRYL and TYLENOL to give to him through out the rest of today and gave her a list of symptoms to look for.
On the day after taking the second dose of Pfizer vaccine shot, I experienced a sharp chest pain and tightness soon after waking up.  However, the pain symptom went away quickly, but my chest muscle has remained tight since then.  The chest muscle between the front of my heart and the back at the point underneath the left scapula has remained tight, seemingly protecting my heart from being burned.  Overall, the chest pain and tightness symptoms are considerably mild, and my chest tightness condition has gradually improved.
1/11/10 Abd pain doctor appt. order CT scan. Findings normal. 1/19/10 spots all over lower extremities, knee and foot swelled up could not walk. Went to ER -diagnosed with HSP. X-rays, labs and transferred to hospital. Stayed overnight discharged in AM 1/20/10. No known cause.
Developed cough 04/29/04. Developed fluid filled blister like rash on trunk and face on 04/30/04.  Afebrile. Areas scabbed in 2-3 days. Using over the counter Claritin as needed.
patient indicated that they were dizzy, nauseous, pain in arm with lightheadedness, high fever for more than 2 days after initiation of the 1st covid vaccine. patient wanted to report that afinitor may be contributing. advised to speak to md and no other information provided. indication: malignant neoplasm of nipple and areola, right female breast
Normal muscle pain; Feeling unwell a little; Has secretion of mucus; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date: unknown), via an unspecified route of administration on 16Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received her first shot of the vaccine last 16Jan2021 and her second shot of the vaccine is scheduled on 06Feb2021. She claims that after the vaccine, she is experiencing the normal muscle pain, feeling unwell a little, and has secretion of mucus. She is asking if it's okay to take the 2nd shot with these types of symptoms. The outcome of the events was unknown.   Information on the batch/lot number has been requested.
Information has been received from a physician concerning a patient who was vaccinated with Gardasil. Concomitant therapy included influenza virus vaccine (unspecified). One day post Gardasil, the patient developed facial palsy (not further specified). The patient outcome was not provided. Additional information is not expected.
Bloody stool; Stool with bad rotten egg smell to it; Stomach started rolling; Facial tremors around right eye; A spontaneous report was received from a consumer concerning a female patient of 70 year old, who was received Moderna's COVID-19 vaccine(mRNA-1273) and experienced facial tremors around right eye, stomach started rolling, bloody stool  and stool with bad rotten egg smell.   The patients medical history included asthmatic spasmodic dysphonia. No relevant concomitant medications were reported.  On 27 Jan 2021, the patient received their first of two planned dose of mRNA-1273 (Lot number: 042L20A) vaccine in the left arm for prophylaxis of COVID-19 infection. On 24 Feb 2021, the patient received their second of two planned dose of mRNA-1273 (Lot number: 011A21A) vaccine in the left arm for prophylaxis of COVID-19 infection.  On 24 Feb 2021, approximately 5 hours after receiving the second dose, the patient's stomach started rolling, and she experienced bloody stool with bad rotten egg smell and facial tremors around right eye. Treatment information for the events included Tylenol.  The patient received both scheduled doses of mRNA-1273; therefore, action taken with the drug in response to the event is not applicable.  The outcome for the events was not provided.; Reporter's Comments: Very limited information regarding the events has been provided at this time.  Further information has been requested.
About two weeks after getting the shot I started having really bad pain on the right side of my head for about 3 days. After the 3rd day I got Bell?s palsy on the right side. The pain in my head is now on both side and continues to this day. I have nerve damage on the right side of my face and chronic pain in both sides of my head.
Patient has lost her ability to sit, crawl, roll over, hold a cup, dress herself and experiences fine tremors of her extremities
Mother of infant states infant received vaccines 7/11/2017 around noon and she had been giving her Tylenol every 4 hours until she fell asleep for the night. She woke up at 2 am infant was having seizure and her temp was 106, she called PCP, who instructed her to take infant to ER. She stayed in ER until temp was down to 102 and then was sent home to be taken to other hospital on 7/12/2017. States hospital did testing, observed the infant and EEG for 48 hours. Hospital informed her that there was no abnormal brain activity and no further seizures noted.
Patient began to experience redness in chest and face at 12:20 pm. Patient denies shortness of breath. Patient given 25 mg  oral Diphenhydramine solution at 12:22 pm. Patient "feeling better" at 12:35 pm. Redness in chest and face subsided at 12:40 pm. Vitals remained within normal limits throughout duration of reaction
The patient has not received the 2nd dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (The patient has not received the 2nd dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (The patient has not received the 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (The patient has not received the 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment details were reported.